Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro

被引：71
|
作者：
Jiang, Xiaosui [1 ]
Crain, Earl J. [1 ]
Luettgen, Joseph M. [1 ]
Schumacher, William A. [1 ]
Wong, Pancras C. [1 ]
机构：
[1] Bristol Myers Squibb Co, Thrombosis Res, Pennington, NJ 08534 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 2009年 / 101卷 / 04期
关键词：
PROCOAGULANT ACTIVITY; HEPARIN-ANTITHROMBIN; BLOOD-COAGULATION; THROMBOSIS; EFFICACY; INACTIVATION; SAFETY;
D O I：
10.1160/TH08-07-0486
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：780 / 782
页数：3
相关论文
共 50 条
  • [31] Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
    Pancras C. Wong
    Donald J. P. Pinto
    Donglu Zhang
    Journal of Thrombosis and Thrombolysis, 2011, 31 : 478 - 492
  • [32] Evaluation of the oral direct factor Xa inhibitor - betrixaban
    Palladino, Michael
    Merli, Geno
    Thomson, Lynda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (11) : 1465 - 1472
  • [33] An oral anticoagulant with direct Factor-Xa-inhibitor
    Weiche, Iris
    NERVENHEILKUNDE, 2010, 29 (05) : 320 - 320
  • [34] Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor
    Abrams, Paris J.
    Emerson, Christopher R.
    PHARMACOTHERAPY, 2009, 29 (02): : 167 - 181
  • [35] Rivaroxaban, the first oral, direct factor Xa inhibitor
    Fassiadis, Nicholas
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (18) : 2945 - 2946
  • [36] EdoxabanA New Oral Direct Factor Xa Inhibitor
    A. John Camm
    Henri Bounameaux
    Drugs, 2011, 71 : 1503 - 1526
  • [37] Edoxaban A New Oral Direct Factor Xa Inhibitor
    Camm, A. John
    Bounameaux, Henri
    DRUGS, 2011, 71 (12) : 1503 - 1526
  • [38] EFFECT OF FAMOTIDINE ON THE PHARMACOKINETICS OF APIXABAN, AN ORAL DIRECT FACTOR Xa INHIBITOR, IN HEALTHY SUBJECTS.
    Uprett, Vijay V.
    Song, Yan
    Wang, Jessie
    Farmer, Mathew
    Pursley, Janica M.
    Li, Tong
    Frost, Charles E.
    LaCreta, Frank P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1117 - 1117
  • [39] Assessment of factor Xa chromogenic assays for measuring the pharmacodynamics of rivaroxaban - an oral, direct factor Xa inhibitor
    Perzborn, E.
    Hardwardt, M.
    Samama, M. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 379 - 380
  • [40] Evaluation of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasis
    Schumacher, W. A.
    Bostwick, J. S.
    Stewart, A. B.
    Xin, B.
    Wong, P. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1001 - 1001
12345